Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.20
-0.29 (-3.87%)
Dec 5, 2025, 4:00 PM EST - Market closed
Exagen Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Exagen stock have an average target of 13.67, with a low estimate of 7.00 and a high estimate of 18. The average target predicts an increase of 89.86% from the current stock price of 7.20.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Exagen stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 3 | 4 | 4 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 4 | 4 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +108.33% | Nov 10, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $15 → $18 | Strong Buy | Reiterates | $15 → $18 | +150.00% | Nov 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $11 → $15 | Strong Buy | Maintains | $11 → $15 | +108.33% | Oct 27, 2025 |
| BTIG | BTIG | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +80.56% | Oct 22, 2025 |
| Keybanc | Keybanc | Buy Maintains $12 → $15 | Buy | Maintains | $12 → $15 | +108.33% | Oct 14, 2025 |
Financial Forecast
Revenue This Year
68.16M
from 55.64M
Increased by 22.50%
Revenue Next Year
78.21M
from 68.16M
Increased by 14.75%
EPS This Year
-0.68
from -0.83
EPS Next Year
-0.35
from -0.68
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 71.9M | 84.6M | ||||
| Avg | 68.2M | 78.2M | ||||
| Low | 65.2M | 74.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 29.3% | 24.2% | ||||
| Avg | 22.5% | 14.7% | ||||
| Low | 17.1% | 8.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.57 | -0.09 | ||||
| Avg | -0.68 | -0.35 | ||||
| Low | -0.78 | -0.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.